China targets a larger role in innovative drug development by 2030

China wants its drug companies to become more competitive by 2030.

It aims to grow sales of new drugs by 20% each year and develop at least a quarter of the world’s first-in-class medicines.

Western drugmakers are signing deals with Chinese companies to add new treatments to their pipelines.

The US is considering limits on some deals, but the article argues that cooperation on medicines should not be treated like a technology contest.